DR Horton Stock Börse Stuttgart

Equities

HO2

US23331A1097

Homebuilding

Market Closed - Börse Stuttgart 01:38:50 2024-05-24 pm EDT 5-day change 1st Jan Change
133 EUR +0.97% Intraday chart for DR Horton -8.75% -3.63%
Sales 2024 * 36.92B 34.05B Sales 2025 * 39.41B 36.34B Capitalization 47.63B 43.91B
Net income 2024 * 4.72B 4.35B Net income 2025 * 5B 4.61B EV / Sales 2024 * 1.33 x
Net Debt 2024 * 1.36B 1.26B Net Debt 2025 * 1.02B 941M EV / Sales 2025 * 1.23 x
P/E ratio 2024 *
10.2 x
P/E ratio 2025 *
9.31 x
Employees -
Yield 2024 *
0.83%
Yield 2025 *
0.89%
Free-Float 73.76%
More Fundamentals * Assessed data
Dynamic Chart
1 week-4.29%
Current month-0.17%
1 month-2.15%
3 months-1.87%
6 months+14.62%
Current year-2.69%
More quotes
1 week
131.64
Extreme 131.64
138.04
1 month
130.94
Extreme 130.94
144.40
3 years
57.18
Extreme 57.18
150.95
5 years
25.80
Extreme 25.8
150.95
10 years
14.74
Extreme 14.735
150.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 98-12-31
Chairman 68 87-12-31
Director of Finance/CFO 58 97-12-31
Members of the board TitleAgeSince
Director of Finance/CFO 58 97-12-31
Director/Board Member 78 14-01-22
Director/Board Member 73 21-04-19
More insiders
Date Price Change
24-05-24 133 +0.97%
24-05-23 131.7 -2.34%
24-05-22 134.9 -2.10%
24-05-21 137.8 +0.44%
24-05-20 137.2 -1.28%

Delayed Quote Börse Stuttgart, May 24, 2024 at 01:38 pm EDT

More quotes
D.R. Horton, Inc. is one of the leading American single-family homebuilders. Net sales break down by activity as follows: - construction of single-family homes and development of lots (90.4%): home sales (detached homes, attached homes, etc.; operating under the names D.R. Horton, America's Builder, Emerald Homes, Express Homes, Freedom Homes and Pacific Ridge Homes) and lot sales; - property rental (7.3%); - supply of financial services (2.3%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
144.6 USD
Average target price
169.8 USD
Spread / Average Target
+17.41%
Consensus